Dual blockade of CD47 and HER2 eliminates radioresistant breast cancer cells

Journal: Nature Communications

Published: 2020-09-14

DOI: 10.1038/s41467-020-18245-7

Affiliations: 13

Authors: 32

Go to article
Institutions Share
UC Davis Department of Radiation Oncology, United States of America (USA) 0.42
UC Davis Comprehensive Cancer Center, United States of America (USA) 0.13
Xiangya Hospital, CSU, China 0.09
UC Davis Department of Biochemistry and Molecular Medicine, United States of America (USA) 0.08
Ludwig Center at the University of Chicago, United States of America (USA) 0.06
UC Davis Department of Surgery, United States of America (USA) 0.03
Kaiser Permanente Vallejo Medical Center, United States of America (USA) 0.03
OSU Department of Pathology, United States of America (USA) 0.03
Department of Radiation Oncology, NU, United States of America (USA) 0.03
NIH NCI Center for Cancer Research (CCR), United States of America (USA) 0.03
Department of Neurology and Neurosurgery, JHU, United States of America (USA) 0.03
UC Davis Department of Internal Medicine, United States of America (USA) 0.02
UC Davis Department of Dermatology, United States of America (USA) 0.02

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER